QuantLogix

MRNA vs PFE — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

engine lead
MRNA
Moderna, Inc. Common Stock
59/100
BUY
$55.63 · +3.27% · $21.5B
Full scorecard →
VS
PFE
Pfizer Inc.
50/100
BUY
$24.67 · +0.61% · $139.9B
62% of similar setups up in 5d
Full scorecard →
Factor by factor — MRNA (left) vs PFE (right)
62
Technical
36
66
Momentum
49
32
Fundamental
64
34
Options
79
59
Microstructure
58

QuantLogix's 5-factor engine currently reads Moderna, Inc. Common Stock (MRNA) at 59/100 (buy) and Pfizer Inc. (PFE) at 50/100 (buy). MRNA carries the stronger composite read by 9 points, led by momentum at 66/100. PFE's strongest leg is options at 79/100. Signals recompute throughout the trading day — the balance can shift with the tape.

Track MRNA with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. MRNA scorecard · PFE scorecard · MRNA earnings · PFE earnings · Today's movers · Verified track record